[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Samir  Vattompadam M.S.", "title": "Senior Vice President of Global Program Leadership", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.07, "open": 8.13, "dayLow": 7.65, "dayHigh": 8.15, "regularMarketPreviousClose": 8.07, "regularMarketOpen": 8.13, "regularMarketDayLow": 7.65, "regularMarketDayHigh": 8.15, "payoutRatio": 0.0, "beta": 0.403, "forwardPE": -2.9588015, "volume": 1669617, "regularMarketVolume": 1669617, "averageVolume": 1529177, "averageVolume10days": 1974350, "averageDailyVolume10Day": 1974350, "bid": 5.78, "ask": 9.89, "bidSize": 2, "askSize": 2, "marketCap": 685697920, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 21.569, "priceToSalesTrailing12Months": 8.233744, "fiftyDayAverage": 6.4303, "twoHundredDayAverage": 7.65865, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 74442760, "profitMargins": -2.36761, "floatShares": 63986017, "sharesOutstanding": 86797200, "sharesShort": 7996034, "sharesShortPriorMonth": 8406094, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0921, "heldPercentInsiders": 0.011460001, "heldPercentInstitutions": 0.95877, "shortRatio": 5.19, "shortPercentOfFloat": 0.0923, "impliedSharesOutstanding": 86797200, "bookValue": 3.52, "priceToBook": 2.2443182, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -197172000, "trailingEps": -2.25, "forwardEps": -2.67, "enterpriseToRevenue": 0.894, "enterpriseToEbitda": -0.34, "52WeekChange": -0.6091044, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 7.9, "targetHighPrice": 40.0, "targetLowPrice": 11.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.0, "recommendationMean": 1.35714, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 630728000, "totalCashPerShare": 7.267, "ebitda": -218828000, "totalDebt": 19473000, "quickRatio": 5.928, "currentRatio": 6.159, "totalRevenue": 83279000, "debtToEquity": 6.374, "revenuePerShare": 0.954, "returnOnAssets": -0.22933, "returnOnEquity": -0.5111, "grossProfits": -114831000, "freeCashflow": -57676124, "operatingCashflow": 124987000, "grossMargins": -1.3788699, "ebitdaMargins": -2.6276503, "operatingMargins": -4.75314, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1756511319, "regularMarketTime": 1756497601, "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -2.10656, "regularMarketPrice": 7.9, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": 3.16455, "postMarketPrice": 8.15, "postMarketChange": 0.25, "regularMarketChange": -0.17, "regularMarketDayRange": "7.65 - 8.15", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1529177, "fiftyTwoWeekLowChange": 2.4900002, "fiftyTwoWeekLowChangePercent": 0.46025884, "fiftyTwoWeekRange": "5.41 - 21.569", "fiftyTwoWeekHighChange": -13.669001, "fiftyTwoWeekHighChangePercent": -0.63373363, "fiftyTwoWeekChangePercent": -60.91044, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.25, "epsForward": -2.67, "epsCurrentYear": -2.23662, "priceEpsCurrentYear": -3.5321155, "fiftyDayAverageChange": 1.4696999, "fiftyDayAverageChangePercent": 0.22855851, "twoHundredDayAverageChange": 0.24135017, "twoHundredDayAverageChangePercent": 0.03151341, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]